长非编码RNA SNHG11的功能及其在三阴性乳腺癌中的工作机制
Tahani Mohamed Ibrahim Al-Hazani1, Wedad Saeed Al-Qahtani2, Maha Abdulla Alwaili3
1Department of Biology, College of Sciences and Humanities, Prince Sattam Bin Abdulaziz University, PO Box 83, Al-Kharj 11940, Saudi Arabia.
Pathology, research and practice
|June 15, 2023
概括
长非编码RNA SNHG11通过调高特异性蛋白2 (SP2) 和粘蛋白1 (MUC-1) 的进展,促进三阴性乳腺癌 (TNBC) 的进展,同时调低microRNA-7-5p. 这项研究揭示了SNHG11.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 三阴性乳腺癌 (TNBC) 对女性来说是一个重大的健康挑战.
- 导致TNBC进展的分子机制需要进一步阐明.
研究的目的:
- 研究TNBC中长非编码RNA (lncRNA) SNHG11的作用和机制.
- 探索涉及TNBC中SNHG11,microRNA-7-5p (miR-7-5p),特异性蛋白2 (SP2) 和粘蛋白1 (MUC-1) 的调控网络.
主要方法:
- 在TNBC组织和细胞中检测SNHG11,miR-7-5p,SP2和MUC-1表达.
- 评估SNHG11和SP2对TNBC细胞恶性行为的影响.
- 使用生物信息学和实验方法预测和验证分子相互作用.
- 对SP2与MUC-1促进体结合的分析.
主要成果:
- 在TNBC中观察到SNHG11,SP2和MUC-1的表达升高.
- SNHG11的敲击抑制了TNBC细胞的进展.
- SP2沉默减弱了SNHG11对TNBC的促进作用.
- SNHG11负调节的miR-7-5p和正调节的SP2.
- SP2直接与MUC-1促进体结合,抑制MUC-1的表达.
结论:
- lncRNA SNHG11促进TNBC细胞的恶性行为,并促进瘤的进展.
- 在TNBC中,SNHG11/miR-7-5p/SP2/MUC-1轴代表了一个新的调节途径.
- SNHG11有可能成为TNBC的治疗点.
更多相关视频
相关概念视频
lncRNA - Long Non-coding RNAs
8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
MicroRNAs
21.4K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.4K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
siRNA - Small Interfering RNAs
16.9K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.9K
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K
The Nucleolus
8.9K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.9K


